Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C., Chen W., Luo J., Batty P., Chen Y-L., Nahler J., Wu Y., Pavord ID., Erpenbeck VJ., Sandham DA., Xue L., Ogg G.

DOI

10.1016/j.jaci.2019.02.015

Type

Journal article

Publication Date

2019-06-01T00:00:00+00:00

Volume

143

Pages

2329 - 2333

Total pages

4

Addresses

MRC Human Immunology Unit and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.

Keywords

Lymphocytes, Humans, Indoleacetic Acids, Pyridines, Receptors, Prostaglandin, Receptors, Immunologic, Cytokines, Cell Aggregation, Immunity, Innate

Permalink More information Close